Akebia Therapeutics, Inc. (AKBA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.26
Day's range
$1.37

Akebia Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 08/07/2026 19.99 M $22.78 M   6.92% 7.41%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 11.32 M $12.91 M   1.39% 4.20%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 9.15 M $10.43 M   410.51% 3.39%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 6.73 M $7.67 M   4.26% 2.50%
STATE STREET CORP 09/22/2026 5.39 M $6.15 M   -53.58% 2.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 08/14/2026 4.27 M $4.87 M   894.49% 1.58%
ACADIAN ASSET MANAGEMENT LLC 08/13/2026 4.00 M $4.56 M   190.83% 1.49%
GOLDMAN SACHS GROUP INC 08/14/2026 3.69 M $4.21 M   2.40% 1.37%
MILLENNIUM MANAGEMENT LLC 08/14/2026 3.20 M $3.64 M   34.05% 1.19%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 2.53 M $2.89 M   14.38% 0.94%
TWO SIGMA INVESTMENTS, LP 08/14/2026 2.44 M $2.78 M   87.75% 0.90%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 2.30 M $2.62 M   14.13% 0.85%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 2.30 M $2.62 M   100.00% 0.85%
NORTHERN TRUST CORP 08/13/2026 2.16 M $2.46 M   11.04% 0.80%
NANTAHALA CAPITAL MANAGEMENT, LLC 08/19/2026 2.00 M $2.28 M   0.00% 0.74%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 1.91 M $2.18 M   7.28% 0.71%
FMR LLC 08/13/2026 1.87 M $2.13 M   40.12% 0.69%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 1.78 M $2.03 M   -25.70% 0.66%
CITADEL ADVISORS LLC 09/02/2026 1.72 M $1.96 M   23.57% 0.64%
UBS GROUP AG 08/13/2026 1.37 M $1.57 M   78.69% 0.51%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 1.22 M $1.40 M   -33.23% 0.45%
CITIGROUP INC 08/03/2026 1.12 M $1.28 M   -60.60% 0.42%
HENNION & WALSH ASSET MANAGEMENT, INC. 07/08/2026 839.73 K $957.29 K   32.61% 0.31%
MORGAN STANLEY 08/13/2026 701.54 K $799.76 K   20.68% 0.26%
INVESCO LTD. 08/14/2026 694.93 K $792.22 K   -3.50% 0.26%
MANGROVE PARTNERS 08/14/2026 666.95 K $760.33 K   77.40% 0.25%
AMERIPRISE FINANCIAL INC 08/14/2026 626.16 K $713.82 K   5,925.98% 0.23%
BANK OF NEW YORK MELLON CORP 08/06/2026 619.15 K $705.83 K   -4.87% 0.23%
NUVEEN, LLC 08/11/2026 596.60 K $680.12 K   0.00% 0.22%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 589.82 K $672.40 K   -18.32% 0.22%
CHOREO, LLC 08/04/2026 562.42 K $641.16 K   100.00% 0.21%
QUANTINNO CAPITAL MANAGEMENT LP 08/13/2026 562.12 K $640.82 K   100.00% 0.21%
CREATIVE PLANNING 08/13/2026 545.74 K $622.14 K   209.09% 0.20%
LOS ANGELES CAPITAL MANAGEMENT LLC 08/13/2026 531.81 K $606.27 K   -11.56% 0.20%
PANAGORA ASSET MANAGEMENT INC 08/06/2026 466.52 K $531.83 K   97.58% 0.17%
BANK OF AMERICA CORP /DE/ 08/14/2026 458.75 K $522.98 K   -83.40% 0.17%
EVERSEPT PARTNERS, LP 08/14/2026 427.10 K $486.89 K   100.00% 0.16%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 358.63 K $408.38 K   -61.10% 0.13%
ALLIANCEBERNSTEIN L.P. 08/14/2026 354.91 K $493.33 K   48.54% 0.13%
CANADA PENSION PLAN INVESTMENT BOARD 08/14/2026 323.60 K $368.90 K   12.56% 0.12%
VIRTUS ETF ADVISERS LLC 08/11/2026 315.74 K $359.94 K   2.51% 0.12%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 308.12 K $352.00 K   23.66% 0.11%
RHUMBLINE ADVISERS 08/12/2026 307.50 K $350.54 K   0.19% 0.11%
RUSSELL INVESTMENTS GROUP, LTD. 08/06/2026 300.37 K $342.42 K   52.81% 0.11%
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO 08/17/2026 294.90 K $336.19 K   100.00% 0.11%
ALPS ADVISORS INC 07/29/2026 272.26 K $310.38 K   24.85% 0.10%
JPMORGAN CHASE & CO 08/12/2026 269.04 K $298.63 K   135.90% 0.10%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 267.30 K $304.72 K   43.94% 0.10%
DEUTSCHE BANK AG\ 08/07/2026 256.88 K $292.85 K   35.57% 0.10%
FRANKLIN RESOURCES INC 08/13/2026 251.01 K $286.16 K   572.94% 0.09%

Akebia Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 262 institutional investors and hedge funds held shares of Akebia Therapeutics Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 19.99 M

VANGUARD CAPITAL MANAGEMENT LLC: 11.32 M

AQR CAPITAL MANAGEMENT LLC: 9.15 M

GEODE CAPITAL MANAGEMENT, LLC: 6.73 M

STATE STREET CORP: 5.39 M

JACOBS LEVY EQUITY MANAGEMENT, INC: 4.27 M

40.90% of Akebia Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 149.73 M shares in the last 24 months. This purchase volume represents approximately $202.14 M in transactions.